Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    51,084.07
    -507.16 (-0.98%)
     
  • CMC Crypto 200

    1,327.45
    -69.08 (-4.95%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Virbac : Declaration of the number of shares and voting rights as of March 2018, 31.


DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

Information on the total number of voting rights and of shares representing the share capital
(Article 223-16 of the General regulations of the French Financial Market Authority - Autorité
des Marchés Financiers)

Quotation place: Euronext Paris
Compartiment B
ISIN code: FR0000031577

Date

Total number of shares representing the share capital

Total number of voting rights

March, 31 2018

8 458 000

Gross total of voting rights : 12 801 610

Net total* of voting rights : 12 765 146

Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.

ADVERTISEMENT

VIRBAC: Shaping the future of animal health
NYSE Euronext - Compartiment B / Code ISIN: FR0000031577 / MNEMO: VIRP
Corporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.com
Website: www.virbac.com

Declaration of the nb of shares and voting rights March 18



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Virbac via GlobeNewswire

HUG#2182163